By Arturo Prins | Project leader
During 2007, ‘Fundación Sales’ used donors’ contributions for its antitumor vaccination program, thus providing 15 researchers with financial funds for them to attend seminars and congresses. These contributions were also used to purchase lab equipment for patient vaccinations, drugs and disposable material.
This was the first stage of the program. We are now about to enter in Phase III, in which we will implement the use of a vaccine against melanoma. The development of cancer vaccines is proceeding at the laboratory and clinical levels. It is undergoing a Phase I clinical trial with 20 patients. A Phase III on 108 patients is set to begin. The Ministry of Science and Technology of Argentina selected our Antitumor Vaccine Program to receive a subsidy from the Interamerican Development Bank of US$1,000,000. They will supply matching funds of 3 dollars for every dollar donated by citizens.
Project reports on GlobalGiving are posted directly to globalgiving.org by Project Leaders as they are completed, generally every 3-4 months. To protect the integrity of these documents, GlobalGiving does not alter them; therefore you may find some language or formatting issues.
If you donate to this project or have donated to this project, you can receive an email when this project posts a report. You can also subscribe for reports without donating.
